Supplemental Table 4 from Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial

Authors:
  • AMAnn M. Mohrbacher
    Ann M. Mohrbacher
  • AYAllen S. Yang
    Allen S. Yang
  • SGSusan Groshen
    Susan Groshen
  • SKShivaani Kummar
    Shivaani Kummar
  • MGMartin E. Gutierrez
    Martin E. Gutierrez
  • MKMin H. Kang
    Min H. Kang
  • DTDenice Tsao-Wei
    Denice Tsao-Wei
  • CRC. Patrick Reynolds
    C. Patrick Reynolds
  • ENEdward M. Newman
    Edward M. Newman
  • BMBarry J. Maurer
    Barry J. Maurer
Open Access
Publisher website
Google Scholar
Abstract
PK Results for 4-HPR and 4-MPR - AUC Over the 1st 48 Hours